Health
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
Key Points
A colored scanning electron micrograph of pancreatic cancer cells. The new drug attacks a mutated cellular protein called KRAS, which fuels nearly all pancreatic cancers, as well as many lung and colon cancers and some other tumor types.
A colored scanning electron micrograph of pancreatic cancer cells. The new drug attacks a mutated cellular protein called KRAS, which fuels nearly all pancreatic cancers, as well as many lung and colon cancers and some other tumor types.